Autoimmune vasculitis is a group of conditions where the immune system inflames blood vessels and limits blood flow. People with autoimmune vasculitis may notice fatigue, fever, weight loss, skin rashes, numbness, sinus trouble, cough, belly pain, or joint aches. Symptoms can develop quickly or slowly and can be short term or long lasting, and not everyone will have the same experience. Many living with autoimmune vasculitis are adults, but children can be affected, and severe cases can be life threatening if vital organs are involved. Treatment often includes steroids and medicines that calm the immune system, and advances in care mean people often manage well with treatment.
Overview
Autoimmune vasculitisSymptoms
Autoimmune vasculitis may begin with flu-like feelings—fatigue, fever, night sweats, and weight loss. Organ symptoms can follow: new rashes or bruiselike spots, sinus or lung trouble, nerve tingling, abdominal pain, or blood in urine. Early symptoms of autoimmune vasculitis vary.
Outlook and prognosis
Many people with autoimmune vasculitis do well when treatment starts early and inflammation is kept under control. Relapses can happen, but prompt care usually restores remission and helps protect organs. Long-term follow-up, heart–kidney monitoring, and healthy habits support better outcomes.
Causes and risk factors
Autoimmune vasculitis arises when the immune system mistakenly attacks blood vessel linings. Risk increases with certain infections (hepatitis B/C), medications, smoking, silica or solvent exposure, and coexisting autoimmune disease. Aging, specific genetic backgrounds, and cancer can also predispose.
Genetic influences
Genetics modestly influence autoimmune vasculitis risk, but no single gene reliably predicts it. Multiple small-effect variants and certain HLA types can raise susceptibility, interacting with infections, smoking, silica, or medications. Family history slightly increases risk; most cases remain sporadic.
Diagnosis
Autoimmune vasculitis is diagnosed using your symptoms and exam, blood and urine tests, and imaging to check affected organs. Doctors often order ANCA testing. A tissue biopsy, when safe and available, provides the most definitive diagnosis.
Treatment and drugs
Treatment for autoimmune vasculitis focuses on calming the immune attack, protecting organs, and preventing flares. Doctors often start with corticosteroids, then add steroid‑sparing medicines like rituximab or other immunosuppressants; treatment intensity matches disease severity. Regular monitoring guides dose changes and relapse prevention.
Symptoms
Autoimmune vasculitis can touch many parts of the body, so symptoms can feel scattered at first—fatigue here, a rash there, maybe sinus pressure or shortness of breath. Symptoms vary from person to person and can change over time. Early symptoms of Autoimmune vasculitis may resemble a viral illness—low fever, aches, and low energy—before organ-specific signs appear. Knowing common patterns can help you notice changes sooner and seek care.
Feeling unusually tired or run-down is common. This can make work or errands feel harder than usual. It may come and go during the day.
Low fevers, night sweats, and chills may appear. You might lose your appetite or a bit of weight without trying. These general symptoms can be among the earliest signs of Autoimmune vasculitis.
Tender red or purple spots on the legs or arms can show up. Clinicians call this purpura, which means small blood spots under the skin. You might also see hive-like bumps or sores that heal slowly.
Achy, stiff joints or sore muscles can develop. Morning stiffness may ease as you move. This pain can flare when Autoimmune vasculitis is active.
How people usually first notice Autoimmune vasculitis?
Many people first notice autoimmune vasculitis when everyday activities suddenly feel harder because of deep fatigue, unexplained fevers, or a flu-like ache that doesn’t pass. Early warning signs often include new rashes or purplish spots on the skin, tingling or numbness in the hands or feet, shortness of breath or a lingering cough, sinus pain or nosebleeds, and swelling or pain in joints; some also see blood in urine or have new high blood pressure if the kidneys are involved. Because these first signs of autoimmune vasculitis can mimic common infections or allergies, it’s the unusual mix, persistence, or worsening of symptoms over days to weeks that typically prompts people to seek care and leads doctors to consider vasculitis.
Types of Autoimmune vasculitis
Autoimmune vasculitis isn’t one single illness; it’s a group of related conditions where the immune system inflames blood vessels. Different “types of autoimmune vasculitis” are defined by the size of vessels involved, certain antibodies in the blood, and hallmark organ patterns. Not everyone will experience every type. Symptoms don’t always look the same for everyone.
Giant cell arteritis
A large-vessel type that often affects arteries in the head and neck, especially in adults over 50. People may notice new temple headaches, jaw pain when chewing, and vision changes.
Takayasu arteritis
A large-vessel form that targets the aorta and its branches, more common in younger adults. Arm fatigue with use, differences in blood pressure between arms, and chest or back pain can show up.
ANCA‑associated vasculitis
A small‑vessel group linked to ANCA antibodies, including GPA, MPA, and EGPA. Common signs include sinus or ear problems, cough or shortness of breath, nerve tingling, and kidney issues like swelling or foamy urine.
Immune complex small‑vessel
Includes IgA vasculitis, cryoglobulinemic vasculitis, and hypocomplementemic urticarial vasculitis. People may develop a raised purplish rash on the legs, joint aches, belly pain, or kidney findings.
Polyarteritis nodosa
A medium‑vessel vasculitis that can affect skin, nerves, gut, and kidneys but usually not the tiny filters of the kidneys. Symptoms can include tender skin bumps, nerve pain or weakness, abdominal pain after meals, and high blood pressure.
Kawasaki disease
A medium‑vessel type seen mainly in children that can involve the heart’s coronary arteries. High fever, red eyes without discharge, strawberry‑like tongue, and peeling skin on fingers or toes are typical features.
Behçet disease
A variable‑vessel vasculitis that can involve both arteries and veins. Mouth and genital ulcers, eye inflammation, skin lesions, and blood clots are common patterns.
Cogan syndrome
A rare form with inflammation affecting the eyes and inner ears. People may have eye pain, light sensitivity, hearing changes, and balance problems.
Central nervous system vasculitis
A subtype limited mainly to brain and spinal cord vessels. Headaches, strokes or transient weakness, confusion, and seizures can occur.
Cutaneous leukocytoclastic
A skin‑limited small‑vessel vasculitis. Painful or itchy purplish spots appear on the lower legs, sometimes with mild fever or joint soreness.
What genetics can tell you about symptoms
Certain HLA gene types, like HLA‑DP and HLA‑DQ variants, can raise the chance of autoimmune vasculitis by making immune cells more likely to attack vessel walls, leading to fatigue, skin rashes, nerve tingling, and kidney or lung problems. Variants in PR3 or MPO genes link to ANCA antibodies, which track with sinus issues, nosebleeds, cough or shortness of breath, and faster‑rising inflammation.
Causes and risk factors
Common risk factors for autoimmune vasculitis include infections, certain medicines, smoking, and exposure to silica dust or air pollution. It starts when the immune system misfires and inflames blood vessel walls, sometimes after a trigger like hepatitis B or C. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Biology also matters, and risk can be higher with older age, female sex in some types, or certain ancestries. Family history, immune system genes, and other autoimmune diseases or asthma can raise susceptibility, but they do not make vasculitis certain.
Environmental and biological risk factors
Autoimmune vasculitis happens when the immune system mistakenly attacks blood vessels, causing inflammation in different parts of the body. Doctors often group risks into internal (biological) and external (environmental). This page focuses on biological and environmental risk factors for autoimmune vasculitis. Risk isn’t caused by just one thing; it reflects how your immune system interacts with infections, medicines, and certain exposures.
Risk rises with age as the immune system changes. Autoimmune vasculitis is more often diagnosed in adults over midlife. Children can be affected, but it is less common for many types.
Sex hormones influence how the immune system reacts. Some forms of autoimmune vasculitis are seen more in women, while others are slightly more common in men. Patterns can vary by the specific type.
Living with another autoimmune condition signals an immune system that’s already overactive. Autoimmune vasculitis can appear alongside diseases like rheumatoid arthritis or lupus. Shared immune pathways may raise susceptibility.
A recent viral or bacterial infection can act as a trigger for vessel inflammation. Immune defenses aimed at germs sometimes spill over and irritate blood vessels. This can set off a longer process in susceptible people.
Genetic risk factors
Genes can shape how the immune system responds, and some changes make autoimmune vasculitis more likely. Researchers have identified several genetic risk factors for autoimmune vasculitis, and patterns can differ by the specific type. Risk is not destiny—it varies widely between individuals. A few rare, single-gene conditions can directly cause vasculitis, while most people have a mix of small-effect variants that raise susceptibility.
HLA class II: Changes in HLA‑DP, HLA‑DQ, or HLA‑DR can tilt immune responses toward misrecognizing vessel proteins. These variants are linked to several forms of autoimmune vasculitis, including ANCA‑associated disease and giant cell arteritis. The specific HLA type tied to risk can differ by ancestry.
HLA-B51 allele: Carrying HLA‑B51 strongly increases the chance of Behçet disease, a vasculitis that can inflame arteries and veins. Many with this gene never develop disease, and impact varies by ancestry. It can support diagnosis alongside clinical features.
HLA-B52 allele: This HLA type is linked to higher risk of Takayasu arteritis, which affects large arteries. Associations appear strongest in some Asian and Latin populations but occur elsewhere. The gene alone does not confirm diagnosis.
PR3 and SERPINA1: Variants near the PR3 gene and in SERPINA1 (alpha‑1 antitrypsin) raise risk of PR3‑ANCA vasculitis. These changes can increase PR3 levels or reduce its regulation, promoting ANCA formation. They are most relevant in granulomatosis with polyangiitis.
MPO and HLA-DQ: MPO‑ANCA vasculitis has been linked to certain HLA‑DQ types. These immune genes influence how myeloperoxidase fragments are presented to T cells. This helps explain why different ANCA types have distinct genetic roots.
IgA pathway genes: Changes in genes that guide IgA production and mucosal immunity can predispose to IgA vasculitis (formerly Henoch–Schönlein purpura). Several HLA types also contribute, and risk patterns differ by age and ancestry. This type of autoimmune vasculitis is more common in children but can occur in adults.
ADA2 deficiency: Inherited loss‑of‑function changes in the ADA2 gene (also called DADA2) can directly cause medium‑vessel vasculitis, often starting in childhood. It is passed in an autosomal recessive pattern when both parents carry the change. Genetic testing can confirm the diagnosis.
UBA1 (VEXAS): An acquired mutation in the UBA1 gene in blood‑forming cells can lead to VEXAS syndrome, which often includes vasculitis in older men. This change is not inherited or passed to children. Recognizing this cause can guide targeted treatment.
Family history: Having close relatives with autoimmune diseases signals shared genetic background that can raise the chance of autoimmune vasculitis. The specific condition in the family may differ, but risk genes often overlap across diseases. This family pattern does not predict severity or timing.
Polygenic risk: Most people with autoimmune vasculitis carry a combination of many small‑effect variants rather than a single causative gene. Together, these variants nudge immune pathways toward overactivity. Current research is mapping these patterns to improve early risk estimates.
Lifestyle risk factors
Certain daily habits can influence the risk, severity, and flare patterns of autoimmune vasculitis. Below is an overview of lifestyle risk factors for Autoimmune vasculitis, focusing on behaviors that can amplify inflammation or complicate management. While none of these habits “cause” the disease on their own, they can meaningfully affect outcomes. Small changes can reduce flares and protect blood vessel health.
Smoking increases vascular inflammation and damages the endothelium. It is linked to higher disease activity and poorer treatment response in autoimmune vasculitis.
Inactivity raises baseline inflammation and impairs vascular function. Regular movement may reduce flare frequency and fatigue in autoimmune vasculitis.
Excess sodium can drive pro‑inflammatory immune pathways and elevate blood pressure. High salt intake may worsen vascular inflammation and organ strain in autoimmune vasculitis.
Refined sugars and trans fats promote systemic inflammation. These dietary patterns may aggravate disease activity and cardiovascular risk in autoimmune vasculitis.
Risk prevention
Autoimmune vasculitis can’t be fully prevented, but you can lower the chance of triggers and catch problems early. Prevention is about lowering risk, not eliminating it completely. The focus is on avoiding infections and exposures that can set off immune reactions, protecting blood vessels, and recognizing early symptoms of autoimmune vasculitis so treatment can start sooner.
Routine vaccines help prevent infections that can stress the immune system and may trigger vasculitis in susceptible people. Ask about flu, COVID‑19, pneumonia, hepatitis, and other vaccines based on your age and risks.
Wash hands, practice safer sex, and keep dental check‑ups to reduce chronic inflammation from infections. If you have risks for hepatitis B or C, get tested and treated to lower vasculitis‑related complications.
Some medicines can rarely trigger vasculitis‑like reactions. Review new prescriptions and over‑the‑counter drugs with your doctor, and report new rashes, fevers, or joint pain after starting a medication.
Smoking promotes blood vessel inflammation and raises the risk of complications if vasculitis occurs. Stopping reduces strain on arteries and improves healing if treatment is ever needed.
Transmission
Autoimmune vasculitis is not contagious. You can’t catch it from someone else, and it doesn’t spread through touch, coughing, sex, or shared food or water.
It also isn’t typically inherited in a simple way; having a relative with an autoimmune condition may raise risk a little, but most people with autoimmune vasculitis have no family history. Some infections, medicines, or environmental exposures can act as triggers in some types, but that’s not transmission of the disease. People often ask about how autoimmune vasculitis is inherited; in most cases, there is no clear genetic transmission of autoimmune vasculitis.
When to test your genes
Autoimmune vasculitis isn’t usually diagnosed by a broad “gene test,” but consider genetic testing if you have early-onset disease, multiple affected relatives, unusual or severe presentations, or overlap with known genetic immune disorders. Testing can refine diagnosis and guide targeted therapies. Discuss options with a rheumatologist and genetic counselor.
Diagnosis
Autoimmune vasculitis is often picked up when new symptoms—like unexplained fatigue, rashes, sinus issues, shortness of breath, or changes in urine—begin to affect day-to-day life. Doctors usually begin with your story and a physical exam, then add targeted tests to confirm what’s going on and check which organs are involved. The diagnosis of Autoimmune vasculitis usually pulls together symptoms, exam findings, and test results to build the clearest picture.
Your clinician asks about symptoms, timelines, and triggers, and examines the skin, nerves, lungs, and joints. Certain patterns raise concern for autoimmune vasculitis. This helps decide which tests come next.
Common labs check inflammation markers and antibodies such as ANCA. These results support the diagnosis of Autoimmune vasculitis but are not the only factor. They also help rule out other causes.
A simple urinalysis looks for blood or protein that can signal kidney involvement. Early kidney changes in autoimmune vasculitis may show up in urine before you feel anything. Follow-up labs track how kidneys are working.
Ultrasound, CT, or MRI can show vessel wall thickening, narrowing, or organ inflammation. Imaging helps spot areas affected by autoimmune vasculitis and guides where to look closer. It also tracks response to treatment over time.
Stages of Autoimmune vasculitis
Autoimmune vasculitis does not have defined progression stages. The course varies by type and from person to person, often flaring and then settling into remission rather than following a steady step-by-step pattern, so clinicians monitor disease activity and organ involvement instead of stages. Diagnosis usually brings together your health story and an exam with blood and urine tests, imaging, and sometimes a small tissue sample; early symptoms of autoimmune vasculitis can be vague at first, such as tiredness, low fevers, skin changes, or new nerve or kidney issues. Different tests may be suggested to help confirm the diagnosis and check which organs are affected.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with autoimmune vasculitis, the first year after diagnosis is the most intense, with flare control and medication adjustments. Once inflammation is quieted, life often becomes more predictable, though monitoring remains essential. Early care can make a real difference, especially when organs like the kidneys, lungs, or nerves are involved, because timely treatment lowers the risk of lasting damage.
Prognosis refers to how a condition tends to change or stabilize over time. With today’s treatments, many living with autoimmune vasculitis reach remission or low disease activity and keep working, parenting, and exercising, with some adjustments. That said, flares can happen, and medicines like steroids or immune-suppressing drugs have side effects that need active management. Severe organ involvement, untreated high blood pressure, infections, or delayed diagnosis raise the chance of complications and, in some forms of autoimmune vasculitis, can affect life expectancy. Asking your care team about early symptoms of autoimmune vasculitis flares—such as new shortness of breath, blood in urine, vision changes, or worsening fatigue—can help you act quickly.
Everyone’s journey looks a little different. Over years, the main goals are preventing flares, protecting organs, and reducing treatment side effects; regular checkups, vaccines, bone and heart health screening, and kidney and lung monitoring all play a part. Support from friends and family can help with medication routines, rides to appointments, and spotting changes early. Talk with your doctor about what your personal outlook might look like, and how your plan can be adjusted as your health and life evolve.
Long-term effects
Autoimmune vasculitis often follows a relapsing-and-remitting course, so the long-term picture can shift over time. Long-term effects vary widely, depending on which blood vessels and organs are involved. Early symptoms of autoimmune vasculitis can be subtle, and earlier diagnosis and treatment often improves the long-term picture. Over years, the main risks come from organ damage, infections, and medication side effects.
Many people cycle through flares and quieter periods. Over time, this pattern can lead to cumulative strain on organs.
Autoimmune vasculitis can inflame kidney filters, leading to protein or blood in urine. Some develop chronic kidney disease and may require dialysis if damage progresses.
Inflammation can leave behind stiff or scarred lung tissue. This may cause breathlessness on hills or stairs and a persistent dry cough.
Irritation of small blood vessels to nerves can cause numbness, tingling, or weakness. Symptoms may settle slowly but sometimes leave lasting changes in sensation or strength.
How is it to live with Autoimmune vasculitis?
Living with autoimmune vasculitis can feel unpredictable: some days you have the energy for work, family, and errands, and other days pain, fatigue, or brain fog slow everything down. Flares may bring new symptoms—such as rashes, numbness, nose or sinus issues, cough, or kidney concerns—while treatment often involves steroids or other immune-calming medicines that can affect sleep, mood, blood sugar, infection risk, and bone health. Many people build routines around rest, medication timing, and regular check-ins with specialists, and they often lean on friends or family for practical help during flares. For those around you, understanding that symptoms can be invisible yet real—offering flexibility, patience, and shared problem-solving—can make daily life steadier for everyone.
Treatment and drugs
Treatment for autoimmune vasculitis aims to calm the overactive immune response, protect organs, and prevent flare-ups. Doctors often start with medicines that quickly reduce inflammation, such as corticosteroids, then add immune-suppressing drugs like methotrexate, azathioprine, mycophenolate, cyclophosphamide, or biologics such as rituximab, depending on how severe the vasculitis is and which organs are involved. A doctor may adjust your dose to balance benefits and side effects, and many people step down to lower-intensity “maintenance” medicines once the condition is controlled. Alongside medical treatment, lifestyle choices play a role, including vaccinations, bone and stomach protection when using steroids, blood pressure and cholesterol control, and regular check-ins and lab tests to catch early symptoms of autoimmune vasculitis returning. Ask your doctor about the best starting point for you, especially if you’re pregnant, planning surgery, or managing infections, since treatment plans often change in those situations.
Non-drug treatment
Autoimmune vasculitis affects blood vessels, so daily choices that protect circulation, joints, skin, and organs can make a meaningful difference. Alongside medicines, non-drug therapies can help reduce flares, maintain strength, and lower complications. Recognizing early symptoms of autoimmune vasculitis—like new rashes, nosebleeds, shortness of breath, or nerve tingling—can guide when to rest, call your care team, or adjust activity. These steps work best when they’re tailored to the type of vasculitis and any organ involvement.
Targeted exercises help maintain strength, flexibility, and balance. A therapist can adapt activities on flare days to protect joints and vessels. Progress is usually gradual and personalized.
Breaking tasks into shorter blocks can prevent overexertion and post-activity crashes. Plan rest between chores, and rotate lighter with heavier tasks. Keep a simple symptom diary to spot your limits.
Handwashing, mask use in crowded indoor spaces, and avoiding sick contacts can reduce infections that may trigger flares. Keep dental care and skin care consistent to lower bacterial risks. Ask about timing around surgeries or dental work.
Staying current with non-live vaccines helps prevent lung and sinus infections. Your care team can advise on timing with immune-suppressing medicines. Keep a written record for clinic visits.
Your genes may have an impact on how drugs work for you
Drugs for autoimmune vasculitis can work differently based on your genes, which influence how fast you process medicines and how strongly your immune system responds. Genetic differences may affect dose needs, side effects, and which treatment is most effective.
Pharmacological treatments
Flares can bring deep fatigue, aching joints, and sudden changes in how you move through a day; medicines aim to calm the immune attack quickly and protect organs. Early symptoms of autoimmune vasculitis can be vague, so treatment often starts as soon as the diagnosis is likely. First-line medications are those doctors usually try first, based on your type of autoimmune vasculitis and which organs are involved. Plans often shift over time to balance control of inflammation with side effects and your life goals.
Prednisone, prednisolone, or methylprednisolone calm inflammation fast in autoimmune vasculitis. Dosing may be increased or lowered gradually to control flares, then taper to the lowest effective dose. Long-term use can raise blood sugar and bone risk, so doctors aim to minimize exposure.
This infusion targets B cells and is commonly used for ANCA-associated autoimmune vasculitis. It can induce remission and help maintain it while reducing steroid needs. Infusion reactions and infections are the main concerns, so monitoring is routine.
This powerful drug is reserved for severe, organ-threatening autoimmune vasculitis. It is usually given for a limited period with steroids to bring disease under control, then switched to a safer maintenance medicine. Blood counts, bladder health, and fertility risks are closely watched.
Weekly low-dose methotrexate can maintain remission in milder autoimmune vasculitis or after stronger drugs. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). Regular blood tests check liver function and blood counts.
Genetic influences
Genetics appears to contribute to who develops autoimmune vasculitis, but it is not the whole story. Having a genetic risk is not the same as having the disease itself. People often ask whether autoimmune vasculitis is hereditary; for most people, it is not directly passed down, though having relatives with autoimmune conditions can raise risk slightly. Research points to small effects from many immune system genes, and these influences can vary by the specific type of vasculitis and by ancestry. Rare single‑gene conditions can cause vasculitis‑like illness, usually beginning in childhood, and those tend to follow clearer inheritance patterns. Environment and exposures—such as infections, smoking, or certain medicines—interact with genetic susceptibility to trigger inflammation in blood vessels. If several relatives are affected or symptoms begin very early, a discussion with a genetics specialist can help decide whether testing might be useful.
Is Autoimmune vasculitis genetic?
Genetics modestly influence autoimmune vasculitis risk, but no single gene reliably predicts it. Multiple small-effect variants and certain HLA types can raise susceptibility, interacting with infections, smoking, silica, or medications. Family history slightly increases risk; most cases remain sporadic.
Pharmacogenetics—how genetics influence drug effects
In autoimmune vasculitis, inherited differences in drug-handling genes can influence how well medicines work and the risk of side effects. Changes in the TPMT and NUDT15 genes can make azathioprine far more likely to cause very low white blood cell counts; lowering the dose or choosing a different medicine can help avoid this. For methotrexate and cyclophosphamide, research links certain genes to differences in how the body breaks them down and to toxicity, but routine pharmacogenetic testing for these drugs in autoimmune vasculitis isn’t standard yet. Some studies suggest that differences in the FCGR3A gene may affect how well rituximab works, but findings are mixed and not used to guide everyday care. Alongside your medical history and other lab results, genetic testing may help guide drug choice or dosing when azathioprine is considered. If you’ve had unusual reactions to medicines or are considering pharmacogenetic testing for autoimmune vasculitis, ask your specialist how the results might change your treatment plan.
Interactions with other conditions
Day-to-day, it can feel like one health issue amplifies the other when autoimmune vasculitis occurs alongside conditions such as rheumatoid arthritis, lupus, or thyroid disease. Doctors call it a “comorbidity” when two conditions occur together, and this pairing can blur the picture—early symptoms of autoimmune vasculitis may be harder to spot if joint pain, rashes, or fatigue are already part of life. Chronic infections, including hepatitis or recurrent lung infections, may complicate treatment because medicines that calm the immune system can raise infection risk, and some infections themselves can trigger flares. High blood pressure, diabetes, and high cholesterol can also interact with autoimmune vasculitis; steroids and inflammation may nudge these problems, which in turn strain the heart, kidneys, and blood vessels. Kidney or lung disease from other causes can add to organ stress when vasculitis is active, so teams often coordinate care to balance treatments and side effects. Interactions can look very different from person to person, and plans usually prioritize infection prevention, blood pressure control, bone and glucose health, and careful timing of vaccines and medicines.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden rashes, joint pain, and fevers that came and went, sometimes followed by numb fingertips or kidney trouble. Families and communities once noticed patterns of lingering fatigue after infections or pregnancies, long before anyone could see what was happening inside blood vessels. Doctors later saw that these scattered clues pointed to inflammation of the vessel walls—what we now recognize as autoimmune vasculitis.
First described in the medical literature as clusters of puzzling syndromes—such as tender purplish spots on the legs, sinus and lung symptoms that wouldn’t settle, or kidney inflammation—autoimmune vasculitis was initially grouped by where it showed up in the body. Early names reflected the organs involved or the size of the affected vessels. Over time, descriptions became more precise as physicians linked shared features, biopsy findings, and characteristic patterns on imaging.
In recent decades, knowledge has built on a long tradition of observation. The arrival of tissue biopsy, better microscopes, and safer imaging allowed clinicians to actually see inflamed vessel walls and the downstream damage to skin, nerves, lungs, and kidneys. Blood tests then added another layer. The discovery of specific autoantibodies, like ANCA, helped explain why the immune system can misfire and target blood vessels, and why certain patterns of symptoms cluster together.
Medical classifications changed as researchers combined what patients feel with what tests show. Instead of only naming the organ involved, modern systems group forms of autoimmune vasculitis by vessel size, antibody patterns, and typical triggers. This shift improved diagnosis, made clinical trials possible, and opened the door to treatments that calm the immune attack rather than only treating complications.
Treatment history reflects this march forward. Before the mid‑20th century, severe forms of autoimmune vasculitis were often fatal. The introduction of corticosteroids, and later immune‑modifying medicines like cyclophosphamide and rituximab, transformed outcomes for many living with autoimmune vasculitis. More recently, targeted therapies and careful use of maintenance medicines have helped reduce relapses and limit side effects, though close monitoring remains essential.
Despite evolving definitions, one theme has stayed constant: autoimmune vasculitis is not a single disease but a family of related conditions that can look different from one person to another. Recognizing early symptoms of autoimmune vasculitis—such as unexplained rashes, persistent sinus issues, cough or shortness of breath, numbness in the hands or feet, or swelling in the legs—has become a key part of care. Knowing this history explains why doctors ask about seemingly unrelated symptoms, order specific blood tests, and sometimes recommend a biopsy. Each step in history has added to the picture we have today, giving people with autoimmune vasculitis a clearer path to diagnosis, treatment, and long‑term follow‑up.